E
agilon health, inc. AGL
$0.44 $0.013.19% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

agilon health, inc. is a healthcare services company that partners with physician groups to support the transition from fee-for-service medicine to value-based care models, primarily within Medicare Advantage. The company operates in the U.S. healthcare services and healthcare technology-enabled services industries, focusing on improving clinical outcomes and managing total cost of care for senior populations. agilon health does not directly provide medical care; instead, it equips physicians with infrastructure, analytics, and operational support to assume and manage financial risk.

The company’s core revenue driver is long-term partnerships with independent and hospital-affiliated physician groups, under which agilon health assumes partial or full financial risk for patient populations and earns revenue based on premium-based arrangements. Its strategic positioning centers on enabling physicians to remain independent while participating in value-based reimbursement at scale. agilon health was founded in 2016 and grew rapidly through new market entry and physician partnerships before completing its initial public offering in 2021, which significantly expanded its capital base and national visibility.

Business Operations

agilon health operates as a single, integrated business focused on value-based care enablement for physician groups. The company generates revenue primarily through capitation and shared savings arrangements tied to Medicare Advantage plans, where it manages medical expenses relative to premium revenue. Its operations include care management programs, clinical analytics, population health tools, and centralized administrative services that support partner physicians.

The company’s operations are primarily domestic, with activities concentrated in the United States. agilon health controls proprietary data analytics platforms, actuarial and risk management capabilities, and care coordination services. It operates through multiple wholly owned operating subsidiaries aligned to regional markets and physician partnerships. The company does not report material international operations or joint ventures, and its partnerships are primarily contractual arrangements with physician groups and health plans rather than equity-based alliances.

Strategic Position & Investments

agilon health’s strategic direction has emphasized disciplined growth, improved risk management, and operational execution following periods of rapid expansion. Growth initiatives have included entering new U.S. markets, deepening relationships with existing physician partners, and refining care models to improve medical cost performance. In recent periods, the company has also prioritized expense control, capital preservation, and reassessment of growth pacing in response to operating losses and volatility in medical cost trends.

The company has historically expanded primarily through organic market entry rather than large-scale acquisitions. Its investments are focused on data analytics, clinical program development, and physician enablement infrastructure rather than owning healthcare facilities or practices. agilon health is actively involved in emerging healthcare models related to population health management, risk-based contracting, and senior-focused care delivery, though outcomes and long-term returns from these initiatives remain dependent on execution and market conditions.

Geographic Footprint

agilon health is headquartered in California and operates across multiple U.S. regions, including the Midwest, Southwest, Northeast, and Pacific Coast. Its market presence spans dozens of local physician markets, each aligned with regional Medicare Advantage plan participation. The company’s geographic strategy focuses on markets with favorable demographics, established physician groups, and strong Medicare Advantage penetration.

The company does not have a meaningful operational presence outside the United States. All revenue is generated domestically, and international investment or expansion has not been disclosed as a strategic priority based on available public information.

Leadership & Governance

agilon health was founded by Steven Sell, who continues to serve as Chief Executive Officer, shaping the company’s physician-centric and partnership-driven strategy. The leadership team emphasizes enabling clinical autonomy for physicians while applying centralized analytics, scale, and financial discipline. Governance is overseen by a board of directors with experience across healthcare services, managed care, and public company operations.

Key executives include:

  • Steven Sell – Chief Executive Officer
  • Jessi Lyon – Chief Financial Officer
  • Gregory Maves – Chief Operating Officer
  • James Riley – Chief Technology Officer
  • David Joyner – Chief Legal and Administrative Officer

The leadership team’s stated strategic vision centers on sustainable value-based care growth, improved cost predictability, and long-term alignment between physicians, patients, and payers.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $175.64
B
AAPL NASDAQ $251.49
B
MSFT NASDAQ $383.00
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $120.72
B
Top Financial Stocks
See All »
B
B
JPM NYSE $289.91
B
V NYSE $304.44
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.16
Top Health Care Stocks
See All »
B
LLY NYSE $910.55
B
JNJ NYSE $235.42
B
AMGN NASDAQ $349.77
Top Real Estate Stocks
See All »
B
PLD NYSE $130.31